Compare SBCF & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBCF | ITGR |
|---|---|---|
| Founded | 1926 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 2009 | 2000 |
| Metric | SBCF | ITGR |
|---|---|---|
| Price | $31.19 | $90.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $38.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 750.6K | 410.4K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | 0.29 | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $45.04 | $1.69 |
| Revenue Next Year | $6.30 | $6.53 |
| P/E Ratio | ★ $107.48 | $187.71 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $27.22 | $62.00 |
| 52 Week High | $35.55 | $123.78 |
| Indicator | SBCF | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 54.33 | 50.21 |
| Support Level | $30.99 | $82.58 |
| Resistance Level | $31.95 | $91.37 |
| Average True Range (ATR) | 0.81 | 2.13 |
| MACD | 0.09 | -0.31 |
| Stochastic Oscillator | 64.03 | 25.83 |
Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.